Patient Views on Managing Fatty Liver Disease Through a Care Programme
Explores patients' expectations and needs before and after a liver disease care programme.
Key facts
- Who runs it
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Where
- Barcelona, SpainSee the site
- Trial code
- Registry title
- Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 3 Jun 2025
- Expected to end
- 20 Jan 2028
- Type of study
- Observational
- Record updated
- 23 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with MASH (a fatty liver disease linked to metabolism) and liver scarring who join a hospital programme in Barcelona. They take part in two interviews about their views and needs.
- Age
- 18 to 75 years
- Sex
- All sexes can join
- Disease stage
- MASH with liver scarring (fibrosis) stage F2-F4, followed in the liver clinic at Hospital de Sant Pau
- Biomarker or test result
- BMI of 27 kg/m² or higher
Main reasons for not taking part
- Decompensated liver cirrhosis
- Moderate-to-severe alcohol use (more than 20 g/day for women, more than 40 g/day for men)
- Type 1 diabetes or other forms of diabetes
- eGFR below 30 mL/min
- Pregnant women or women planning to become pregnant
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Patients who voluntarily agree to participate in the MASH-Cardiovascular Programme
- Patients followed in the outpatient hepatology/gastroenterology clinic at Hospital de Sant Pau with a diagnosis of MASH and fibrosis stage F2-F4
- Patients aged between 18 and 75 years
- Patients with a BMI ≥ 27 kg/m²
- Patients who consent to participate in the study-specific interviews
Who cannot take part
- Patients who are candidates for bariatric surgery
- Patients with type 1 diabetes or other forms of diabetes
- Patients with active malignancy
- Patients with advanced or unstable heart failure
- Patients with eating disorders or severe psychiatric illness
- Patients with an eGFR < 30 mL/min
- Patients who do not agree to participate in the study-specific interviews
- Patients meeting exclusion criteria of the MASH-Cardiovascular Programme:
- Patients with decompensated liver cirrhosis
- Patients who are vegetarians or have dietary habits/preferences that prevent adherence to standard-of-care nutritional guidelines
- Patients with moderate-to-severe alcohol consumption (>20 g/day for women and >40 g/day for men)
- Patients with malnutrition
- Patients currently enrolled in another clinical trial
- Pregnant women or women planning to become pregnant
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in Spain
- IR Sant PauBarcelona, SpainContact: Marina Idalia Rojo López BarcelonaTaking people
About the trial
What the trial wants to find out
The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona.
Read full original descriptionShow less
The main research question is:
What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention?
Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Perspectives on the Multidisciplinary Approach to Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study With Patients From the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona
- Plain-language title
- Patient Views on Managing Fatty Liver Disease Through a Care ProgrammeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07188220, who can take part
- Record updated
- 23 September 2025